Braveheart Investment Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Braveheart Investment Group şirketinin toplam hissedar öz sermayesi £3.5M ve toplam borcu £0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £3.5M ve £43.6K dir.

Anahtar bilgiler

Borç/özkaynak oranı

UK£0

Borç

Faiz karşılama oranı	n/a
Nakit	UK£1.09m
Eşitlik	UK£3.46m
Toplam yükümlülükler	UK£43.60k
Toplam varlıklar	UK£3.50m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BRH 'nin kısa vadeli varlıkları ( £1.2M ) kısa vadeli yükümlülüklerini ( £43.6K ) aşıyor.

Uzun Vadeli Yükümlülükler: BRH un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BRH borçsuzdur.

Borcun Azaltılması: BRH un 5 yıl önce borcu yoktu.

Borç Kapsamı: BRH un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: BRH şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Braveheart Investment Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

First half 2025 earnings released: EPS: UK£0.001 (vs UK£0.011 loss in 1H 2024)

Braveheart Investment Group plc (AIM:BRH) acquired 29.51% stake in IQ-AI Limited (LSE:IQAI) from Trevor Brown and Free Association Books Limited for £0.719 million.

Braveheart Investment Group plc (AIM:BRH) acquired an additional 15% stake in Gyrometric Systems Limited for £0.0225 million.

Insufficient new directors

Full year 2024 earnings released: UK£0.11 loss per share (vs UK£0.027 profit in FY 2023)

Braveheart Investment Group plc, Annual General Meeting, Jul 18, 2024

Bruker Uk Limited completed the acquisition of Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders.

Bruker Uk Limited entered into a conditional sale and purchase agreement to acquire Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders for £5 million.

First half 2024 earnings released: UK£0.011 loss per share (vs UK£0.01 loss in 1H 2023)

New minor risk - Share price stability

New major risk - Market cap size

Braveheart Investment Group plc, Annual General Meeting, Jul 28, 2023

Full year 2023 earnings released: EPS: UK£0.027 (vs UK£0.031 in FY 2022)

Less than half of directors are independent

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.049 profit in 1H 2022)

Braveheart Investment Group plc (AIM:BRH) acquired additional 4.7% stake in Autins Group plc (AIM:AUTG) for £0.16 million.

Braveheart Investment Group plc (AIM:BRH) acquired additional 8.31% minority stake in Aukett Swanke Group Plc (AIM:AUK) from Andrew Murdoch for £0.33 million.

Braveheart Investment Group plc (AIM:BRH) agreed to acquire a 7.89% stake in Aukett Swanke Group Plc (AIM : AUK) from Trevor Brown for £0.22 million.

Braveheart Investment Group plc Provides the Update on Paraytec

Full year 2022 earnings released: EPS: UK£0.031 (vs UK£0.37 in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

First half 2022 earnings released: EPS UK£0.049 (vs UK£0.013 in 1H 2021)

Braveheart Investment Group plc Announces Further Update re Paraytec AD Scanner Project

CEO & Director recently sold UK£556k worth of stock

Full year 2021 earnings released

Braveheart Investment Group plc Updates on the Paraytec AD Scanner Project

David Orton, Paul Orton and Janet Poliakoff agreed to acquire a 56.07% stake in Gyrometric Systems Limited from Braveheart Investment Group plc (AIM:BRH) and Remote Monitored Systems plc (AIM:RMS).

CEO & Director recently sold UK£827k worth of stock

Independent Non-Executive Director has left the company

CEO & Director recently sold UK£1.7m worth of stock

CEO & Director recently sold UK£689k worth of stock

New 90-day high: UK£0.80

Braveheart Investment Group plc Provides Update Concerning Progress to Develop Covid-19 Test That Paraytec Limited Is Working on in Conjunction with the University of Sheffield

CEO & Director recently sold UK£214k worth of stock

First half 2021 earnings released: EPS UK£0.013

New 90-day high: UK£0.47

New 90-day high: UK£0.37

Remote Monitored Systems plc (AIM:RMS) agree to acquire 51.72% stake in Pharm 2 Farm Limited from Braveheart Investment Group plc (AIM:BRH) for £1.2 million.

Braveheart Investment Group plc Update on the Pharm2farm Anti-Viral Mask Project

New 90-day high - UK£0.21

New 90-day high - UK£0.21

New 90-day high - UK£0.20

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin